Environmental, Social And Governance Report

Overview

The report highlights Hengrui Pharma's 2021 innovation achievements, including ten innovative drugs approved for marketing in China. It establishes the Board of Directors as the ultimate ESG decision-making body and reports 244,060.25 Tonnes of Carbon Dioxide Equivalent in total greenhouse gas emissions. The workforce totaled 24,491 people, while the report also describes environmental management, employee development, and occupational safety initiatives.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Publication date: 21 April 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services